120 related articles for article (PubMed ID: 21984457)
1. African programme for Onchoceriasis control: ophthalmological findings in Bushenyi, Uganda.
Babalola OE; Ogbuagu FK; Maegga BT; Braide EI; Magimbi C; Zoure H; Yameogo L; Seketeh A
West Afr J Med; 2011; 30(2):104-9. PubMed ID: 21984457
[TBL] [Abstract][Full Text] [Related]
2. APOC impact assessment studies: baseline ophthalmological findings in Morogoro, Tanzania.
Babalola OE; Maegga B; Katenga S; Ogbuagu FK; Umeh RE; Seketeli E; Braide E
Afr J Med Med Sci; 2008 Dec; 37(4):327-32. PubMed ID: 19301709
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and distribution of ocular onchocerciasis in three ecological zones in Nigeria.
Umeh RE; Mahmoud AO; Hagan M; Wilson M; Okoye OI; Asana U; Biritwum R; Ogbu-Pearce P; Elhassan E; Yaméogo L; Braideo EI; Seketeli A
Afr J Med Med Sci; 2010 Dec; 39(4):267-75. PubMed ID: 21735992
[TBL] [Abstract][Full Text] [Related]
4. Concurrence of dermatological and ophthalmological morbidity in onchocerciasis.
Coffeng LE; Fobi G; Ozoh G; Bissek AC; Nlatté BO; Enyong P; Olinga JM; Zouré HG; Habbema JD; Stolk WA; de Vlas SJ; Boussinesq M; Noma M
Trans R Soc Trop Med Hyg; 2012 Apr; 106(4):243-51. PubMed ID: 22342170
[TBL] [Abstract][Full Text] [Related]
5. The problem of trachoma within an onchocerciasis-endemic zone in Kaduna: need for a multilateral approach?
Babalola OE; Abiose A; Barrie JR
Ophthalmic Epidemiol; 2005 Oct; 12(5):311-9. PubMed ID: 16272051
[TBL] [Abstract][Full Text] [Related]
6. Onchocerciasis as a risk factor for night blindness.
Babalola OE
Ophthalmic Epidemiol; 2012 Aug; 19(4):204-10. PubMed ID: 22775275
[TBL] [Abstract][Full Text] [Related]
7. Profile of eye lesions and vision loss: a cross-sectional study in Lusambo, a forest-savanna area hyperendemic for onchocerciasis in the Democratic Republic of Congo.
Kayembe DL; Kasonga DL; Kayembe PK; Mwanza JC; Boussinesq M
Trop Med Int Health; 2003 Jan; 8(1):83-9. PubMed ID: 12535256
[TBL] [Abstract][Full Text] [Related]
8. Onchocerciasis and other eye problems in developing countries: a challenge for optometrists.
Berger IB; Nnadozie J
J Am Optom Assoc; 1993 Oct; 64(10):699-702. PubMed ID: 8245390
[TBL] [Abstract][Full Text] [Related]
9. Traditional kinship system enhanced classic community-directed treatment with ivermectin (CDTI) for onchocerciasis control in Uganda.
Katabarwa MN; Habomugisha P; Agunyo S; McKelvey AC; Ogweng N; Kwebiiha S; Byenume F; Male B; McFarland D
Trans R Soc Trop Med Hyg; 2010 Apr; 104(4):265-72. PubMed ID: 20106493
[TBL] [Abstract][Full Text] [Related]
10. Ocular health status of rural dwellers in south-western Nigeria.
Adegbehingbe BO; Majengbasan TO
Aust J Rural Health; 2007 Aug; 15(4):269-72. PubMed ID: 17617092
[TBL] [Abstract][Full Text] [Related]
11. Effects of Ivermectin with and without doxycycline on clinical symptoms of onchocerciasis.
Masud H; Qureshi TQ; Dukley M
J Coll Physicians Surg Pak; 2009 Jan; 19(1):34-8. PubMed ID: 19149978
[TBL] [Abstract][Full Text] [Related]
12. Burden of moderate visual impairment in an urban population in southern India.
Dandona L; Dandona R; Naduvilath TJ; McCarty CA; Srinivas M; Mandal P; Nanda A; Rao GN
Ophthalmology; 1999 Mar; 106(3):497-504. PubMed ID: 10080205
[TBL] [Abstract][Full Text] [Related]
13. The Pakistan national blindness and visual impairment survey--research design, eye examination methodology and results of the pilot study.
Bourne R; Dineen B; Jadoon Z; Lee PS; Khan A; Johnson GJ; Foster A; Khan D;
Ophthalmic Epidemiol; 2005 Oct; 12(5):321-33. PubMed ID: 16272052
[TBL] [Abstract][Full Text] [Related]
14. Visual field constriction as a cause of blindness or visual impairment.
Murdoch IE; Jones BR; Cousens S; Liman I; Babalola OE; Dauda J; Abiose A
Bull World Health Organ; 1997; 75(2):141-6. PubMed ID: 9185366
[TBL] [Abstract][Full Text] [Related]
15. Blindness and vision impairment in a rural south Indian population: the Aravind Comprehensive Eye Survey.
Thulasiraj RD; Nirmalan PK; Ramakrishnan R; Krishnadas R; Manimekalai TK; Baburajan NP; Katz J; Tielsch JM; Robin AL
Ophthalmology; 2003 Aug; 110(8):1491-8. PubMed ID: 12917162
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological impact of vector control. II. Changes in ocular onchocerciasis.
Dadzie KY; Remme J; De Sole G
Acta Leiden; 1990; 59(1-2):127-39. PubMed ID: 2378201
[TBL] [Abstract][Full Text] [Related]
17. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and causes of visual impairment and blindness in Icelanders aged 50 years and older: the Reykjavik Eye Study.
Gunnlaugsdottir E; Arnarsson A; Jonasson F
Acta Ophthalmol; 2008 Nov; 86(7):778-85. PubMed ID: 18513265
[TBL] [Abstract][Full Text] [Related]
19. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.
Xu L; Wang Y; Li Y; Wang Y; Cui T; Li J; Jonas JB
Ophthalmology; 2006 Jul; 113(7):1134.e1-11. PubMed ID: 16647133
[TBL] [Abstract][Full Text] [Related]
20. Low vision in persons aged 50 and above in the onchocercal endemic communities of Anambra State, Nigeria.
Nwosu SN
West Afr J Med; 2000; 19(3):216-9. PubMed ID: 11126088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]